Azathioprine neutropenia — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Urgent prescriber contact and withholding azathioprine pending clinical review
Azathioprine can cause bone marrow suppression, and neutropenia with fever is a serious safety concern. The prescriber or specialist team should be contacted urgently and the medicine withheld pending review according to local shared-care guidance. Routine monitoring in several months would be unsafe. Amylase may be relevant for pancreatitis symptoms but does not address the current neutropenic sepsis risk.
Reference: BNF; Specialist Pharmacy Service monitoring guidance